In this retrospective study, we determined the incidence, predictive factors, and outcomes for early AKI (within 48 hours), defined according to the KDIGO guidelines, occurring after abdominal surgery in elderly patients(≥ 75y). The incidence of AKI was 7.9% and that 0.61% required renal replacement therapy. After controlling for confounding variables, old age, preoperative hepatic dysfunction and intraoperative combined administration of HES and furosemide were identified as independent predictors for AKI. Furthermore, ICU stay and in-hospital mortality increased with occurrence of AKI.
Postoperative AKI remains a leading cause of mortality, prolonged hospital stay, and increased hospital cost. Kim M et al. [1] and Kheterpal S et al.[12]reported a rate of 1.1% and 1.0% after intraabdominal surgery. Causey MW et al. [13] reported an incidence of 11.8% in patients submitted to colorectal surgery. Teixeira et al. [3] found an AKI incidence of 22.4% after abdominal surgery. However, direct comparison of these studies is difficult, as the judgment criteria of AKI and age restrictions were inconsistent. But we strictly control these factors in the inclusion criteria in this study.
Previous studies had reported many risk factors for AKI after abdominal surgery such as old age, male gender, liver disease, higher BMI, CKD, Hydroxyethyl starch, use of diuretics and vasopressors [2, 3, 7, 14–16]. Age is a well-known risk factor for renal function impairment in many studies[2, 8], since the capacity of the kidney to adapt to hemodynamic changes declines with age, even minor injury can produce function impairment due to this natural phenomenon. There were also many studies report that postoperative AKI is associated with preoperative liver function damage[2, 17]. These were all consistent with our findings.
Large multicenter non-blinded randomized control trials (RCTs) and meta-analyses have raised concerns about the safety of HES solutions in terms of adverse renal events and mortality [18–20]. After assessing the data submitted by the companies and scientific literatures, the European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) suggested that patients treated with HES were at greater risks of kidney injury when compared with crystalloids[21]. Many studies reported that diuretics can also increase the risk of AKI[2, 18, 22, 23], especially loop diuretics[24], and the degree of renal injury was believed to be positively correlated to the dose of diuretic[25–28]. Research has shown that combination of diuretics and other nephrotoxic agents could lead to renal dysfunction more than diuretics alone[29], Therefore, the recent KDIGO guidelines do not recommend the use of loop diuretics for prevention or treatment of AKI[10]. In present study, although HES administration alone in operation has no statistical difference between subgroups of patients with and without AKI, incidence of postoperative AKI was considerably increased in patients with combined administration of HES and diuretics. It was consistent with Landoni G’s study [30].We infer that HES and diuretics might increase the risk of postoperative AKI when combined administration in surgeries. This discovery was of great value to anesthesiologists in managing intraoperative medications. They should avoid the combination HES with furosemide to reduce the risk of postoperative AKI for elder patients.
Studies have confirmed that male sex[23], preoperative lower ALB[17, 20, 23] and intraoperative hypotension[31, 32] are risk factors for postoperative AKI. In our study, although these factors were significantly associated with postoperative AKI in univariate analysis, they were independent risk factors after adjusting for age and intraoperative nephrotoxicity in multivariate analysis. It may be related to the small sample size we collected.
In our study, postoperative AKI after abdominal surgery significantly increased the lengths of ICU stay after operation, medical costs and in-hospital mortality. This finding was consistent with various previous studies[3, 6, 8, 20, 23, 33, 34].
A major innovation of this study was that, for the first time, all patients were at age of 75 years and above. Meanwhile, despite its retrospective design, many covariates with impacts on AKI development and outcome were analyzed. Furthermore, mortality data were collected completely for all patients. However, there were several limitations in this study. First, the single-center nature of the study largely limited its generalizability. Second, we did not have reliable information on urine output for the patient cohort. Using urine output data in addition of SCr might define more AKI cases in the patients.